Head of EU pharma trade body says waiver would ‘open the door to counterfeit vaccines’ and kill incentives to tackle dangerous virus variants. ‘Who will make the vaccine next time?’ one pharma chief asks
As COVID-19 shows, older people are particularly vulnerable to infectious diseases. IMI’s VITAL project is studying vaccines and immunity in older adults, to figure out the best strategies to keep people healthier for longer.
At first event to be jointly organised by European Innovation Council and European Institute of Innovation and Technology, entrepreneurs call for EU to fill gaps in support and funding their companies need to scale up and be profitable
Relief bill has money to help researchers over the COVID-19 crisis and fill gaps in US response, such as viral genome sequencing and zoonotic disease work. But some say it is a fraction of what is needed for science to recover fully
Universities are caught in the cross fire of the pandemic. While the value of their research has never been more evident, the quality of online learning is questioned. How will university rankings respond?